Advances in polyglutamine disease research & therapy

Slides:



Advertisements
Similar presentations
Molecular Genetics DNA RNA Protein Phenotype Genome Gene
Advertisements

Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
 Dominant neurodegenerative disease  Polyglutamine repeat expansions (CAG, codon, Q) in exon 1 of huntingtin gene (htt). Usually >35 CAG repeats. 
FOLLOWING PATTERNS OF INHERITANCE. GENETIC TESTS Types of Genetic Tests a)Karyotype b)Fluorescence in situ hybridization c)Gene testing d)Biochemical.
Revisions to the “central dogma” of molecular biology over the last 10 years, scientists have discovered an entirely new category of non-coding RNA genes.
MECHANISMS OF AGING TheoryPrinciples DNA & Genetic Theory Aging is predetermined by genetic programming. Neuroendocrine Theory Loss of hypothalamic regulation.
Chapter 18 Human Heredity by Michael Cummings ©2006 Brooks/Cole-Thomson Learning Chapter 18 Genetics of Behavior.
L and D isomers of amino acids. Ionization state as a function of pH.
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
HUNTINGTON’S DISEASE BY ERIN DALTON WHAT IS IT? A degenerative brain disorder which currently there is no cure or effective treatment for it. Huntington’s.
How Genes Are Transmitted from Generation to Generation
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Diseases That Result from Expansion of Trinucleotide Repeats Type Ⅱ trinucleotide repeat diseases xuyan.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
Huntington’s Disease Michael Ou Pierce Lam.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
Nature vs. Nurture.  Once nurture seemed clearly distinct from nature. Now it appears that our diets and lifestyles can change the expression of our.
Genes as DNA: How Genes Encode Proteins
CHAPTER 18 Molecular Biology and Medicine
HEREDITARY ATAXIA ZEESHAN GAUHAR PhD SCHOLOR-BIOTECHNOLOGY
Holly Allen CREUTZFELDT-JAKOB DISEASE.  Human equivalent of mad cow disease  Rare, degenerative, fatal disease  Approximately 1 case per million per.
Molecular Biology In Medicine
Do Now : Think-Pair-Share For a height characteristic when tall is dominant What would be the phenotypic ratio for offspring of heterozygous and homozygous.
By : Amirah nu’aimi Sharifah Nurul Hanim TASK 2 – DISCUSS THE EXAMPLE OF PROTEIN FOLDING DISEASE BY STATING THE MECHANISM.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Trinucleotide repeats (TNRs) Dr. Derakhshandeh, PhD.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Small Scale Mutations & Gene Expression. LARGE MUTATIONS & GENETICS Quick Review.
End Show Slide 1 of 43 Copyright Pearson Prentice Hall 14–1 Human Heredity 14-1 Human Heredity.
MUTATIONS & HUMAN GENETICS Chapter 11.3, Chapter 12.
Michael Cummings David Reisman University of South Carolina Gene Regulation Part 2 Chapter 9.
Because Stuff Happens Mutations.
Genes and Proteins Lecture 2 PSY391S John Yeomans.
5.2.  Differences or variation in DNA are what makes us different from each other!  Each human cell contains 46 chromosomes  Each cell has 3 billion.
 slowly progressive, degenerative, and fatal disease affecting the central nervous system of adult cattle.  abnormal version of a protein normally found.
Protein Synthesis. Learning Objectives By the end of this class you should understand: The purpose and mechanism of codons The two steps of protein synthesis.
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells (Irina V. Kovtun et al., Nature, 2007) Yizhang Chen 10/18/2012 Student Presentation.
Lecture Topic: “Genetic Control of Cellular Function/Gene Technology” l Explain the mechanisms whereby genetic information is passed from one generation.
Cancer Genetics Case Studies.
Uncommon neurological conditions and possible advances in their management By Andrey Pashvykin.
Chapter 3 Genes in Pedigrees Mendelian Pedigree Patterns:
Under the supervision of miklós jászberényi
PARTIAL LOSS OF TIP60 SLOWS MID-STAGE NEURODEGENERATION IN A SPINOCEREBELLAR ATAXIA TYPE 1 (SCA1) MOUSE MODEL -KRISTEN M. GEHRKING, J. MICHAEL ANDRESEN,
Clinical Features Huntington’s disease is a rapidly progressive neurodegenerative disease that leads to dementia. Typically presents with alterations.
Dentatorubral- pallodoluysian Atrophy (DRPLA). DRPLA Trinucleotide Repeat Disorder Trinucleotide Repeat Disorder CAG repeat on Chromosome 12 CAG repeat.
Genetic Disorders Genetic Mutations Because DNA controls characteristics of a cell it must be copied before a cell reproduces Sometimes mistakes occur.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Disease That Result from Expansion of Trinucleotide Repeats Tianyang Wang.
GENETICS Dr. Samar Saleh Assiss. Lecturer Mosul Medical College Pathology3 rd year.
HUNTINGTON’S DISEASE Neil Madadi. WHAT IS HUNTINGTON’S DISEASE?  It is an autosomal dominant inherited disease. Meaning that only one copy of the altered.
Mutations. Recall: DNA is made up of a sequence of nucleotides. A nucleotide is composed of a deoxyribose sugar, a phosphate group and a nitrogenous base.
Because Stuff Happens. A. Mutation Overview  Any change or random error in the nucleotide sequence (either DNA or mRNA) is called a mutation  Can occur.
GENETICS 101 & WHOLE GENOME SEQUENCING Vikram Shakkottai, MD, PhD.
Patterns of single gene inheritance Mahmoud A. Alfaqih BDS PhD Jordan University of Science and Technology School of Medicine Department of Biochemistry.
CLINICAL CORRELATIONS
(Draw and label a picture of a neurone here)
Protein Folding Diseases
CLINICAL CORRELATIONS
Neurodegeneration caused by prions. A
Neurodegenerative diseases and triplet expansion
Long Term Effects of Concussions
Mutations & Genetic Engineering
Different mode and types of inheritance
Relationship between Genotype and Phenotype
Mutations & Genetic Engineering
CLINICAL CORRELATIONS
Relationship between Genotype and Phenotype
RNA and Disease  Thomas A. Cooper, Lili Wan, Gideon Dreyfuss  Cell 
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
Presentation transcript:

Advances in polyglutamine disease research & therapy Albert La Spada, M.D., Ph.D. Professor of Pediatrics and Cellular & Molecular Medicine Division Chief of Genetics, Dept. of Pediatrics Associate Director, Institute for Genomic Medicine NAF meeting March 18, 2011

Advances in molecular genetics fueled a decade (or so) of discovery (1988-2000)

CAG = glutamine (Q)

CAG / polyglutamine repeat diseases Spinal & bulbar muscular atrophy Huntington’s disease Dentatorubral pallidoluysian atrophy Spinocerebellar ataxia 1, 2, 3, 6, 7 & 17 all affect the nervous system all are dominant (except SBMA which is X-linked) all comparable median ages of onset all are slowly progressive all show a correlation between increasing expansion size and disease severity - this correlation + tendency of the repeats to expand when transmitted from parent to child explains: ANTICIPATION all are caused exclusively by CAG repeat expansions that are translated into polyglutamine tracts (except SCA6)

successive generations SCA7 pedigree (UWMC Neurogenetics Clinic) - presented with coordination problem in her late 60s d. 80 yo Example of ANTICIPATION = worsening of disease phenotype in successive generations ? - presented at age 50 with visual problems; ataxia / spasticity d. 63 yo - blind, walks with cane; 50 CAGs - presented with visual problems at age 6; developed ataxia, went blind, cognitive decline 38 yo 36 yo d. 16 yo - dysarthria, ataxia, and central scotoma 48 CAGs

...CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG...  DNA sequence = trinucleotide repeat expansion …QQQQQQQQQQQQQQQQQQQQQQQ... Amino acid sequence = glutamine tract expansion Protein product = misfolded conformation

Formation of protein aggregates in neurodegeneration: a common link Disease Implicated protein Histopathology CAG / polyQ Various Nuclear inclusions diseases (e.g. HD) Alzheimer’s dz APP, apoE, others Neurofibrillary tangles & beta-amyloid plaques Parkinson’s dz synuclein, others Lewy bodies ALS (Lou Gehrig’s) TDP-43 Bunina bodies Jacob-Creutzfeldt prion Prions (mad cow disease)

Towards Therapy

Normal cell in the body DNA (genes) Protein Messenger RNA The central dogma of biology DNA – RNA- protein Protein is essential for basic biological function and participate in every process that happens inside the cell

Cell affected By SCA7 Abnormal DNA Protein Toxic Incorrect message

Andrew Fire and Craig Mello won the Nobel Prize in 2006 for their discovery of RNA interference Andrew Fire Stanford University Craig Mello University of Massachussets

RNA interference was first discovered in plants and worms Petunias Round worms

RNA interference targets the messenger DNA (genes) protein

RNA interference is a promising therapy for many different diseases: Huntington’s disease 2. Other degenerative brain disorders Cancer 4. HIV

RNAi as a therapy for SCA7 X Trafficking defects Therapy targets in SCA7 X mutant atx7